Salidroside, the primary active compound of Rhodiola rosea (Crassulaceae family), is a phenylethanoid glycoside with CAS number 10338-51-9. Known for its anti-fatigue, anti-hypoxia, neuroprotective, and antidepressant effects, it was listed in the European Medicines Agency (EMA) traditional herbal medicine registry in 2022 and serves as a quality control marker for Rhodiola in the Chinese Pharmacopoeia (2020 edition).
Product Name: Salidroside
IUPAC Name: 2-(4-Hydroxyphenyl)ethyl-β-D-glucopyranoside
CAS No.: 10338-51-9
Molecular Formula: C₁₄H₂₀O₇